The FDA is in the process of certifying psilocybin for therapeutic purposes, research should begin within a year or two, but decriminalization in oakland has already led to high quality, precision-dosed, retail-available gelcaps and such. I'm hoping those products hop the bay and show up in SF head shops, soon.
What conditions are they considering it for?
Amen to that. Also, hope that this will pave the way for wider therapeutic use not just in SF, but across the US and other countries.
Reducing stigma helps research. It becomes easier to get institutional support, recruit study participants, collaborate with colleagues, obtain funding, etc.